ESTABLISHED 2024 A CIVIC RECORD OF ACTIONS TAKEN AGAINST THE AMERICAN PEOPLE — AND HOW WE RESTORE THEM July 12, 2026
A nonpartisan civic restoration project

UndoTrump.com

★   ★   ★

Tracking every rollback, reversal, and overreach — and the path back to the America we know.

1,233
Actions Tracked
967
Still Active
43
In the Courts
40
Restored
538
Days Tracking

🏥 Healthcare

63 Actions  ·  Page 2 of 7
Active

Trump Administration Overhauls CDC Vaccine Recommendations

The Trump administration's changes to CDC vaccine guidance resulted in the loss of recommendations for several vaccines including flu and Covid shots. A judge's stay on these changes created uncertainty about vaccine access in some states, while a halted vaccines committee prevents new recommendations from being made. This directly impacts Americans' access to preventive vaccines and future vaccine development.

Active

Trump Administration Shifts Title X Program Away from Birth Control

The Trump administration redirected the Title X family planning program to de-emphasize hormonal birth control provision at health clinics. This policy shift changes the program's core focus despite clinics receiving delayed funding. The change directly impacts women's access to contraception through federally-funded clinics nationwide.

Active

Trump Administration Imposes 100% Tariffs on Patented Pharmaceuticals

The Trump administration announced 100% tariffs on patented drugs to force pharmaceutical companies into pricing negotiations and shift manufacturing to America. This action leverages tariff threats to compel drugmakers into 'most-favored nation' pricing deals. The policy directly impacts drug prices and availability for American consumers while pressuring companies to relocate production domestically.

Active

Strategic Active Pharmaceutical Ingredients Reserve Executive Order

Executive Order 14336 directs the establishment and filling of a Strategic Active Pharmaceutical Ingredients Reserve to strengthen domestic pharmaceutical supply chains. The order aims to reduce U.S. dependence on foreign sources for critical drug components and improve resilience against supply disruptions. Americans may see increased availability and potentially lower costs for essential medications through enhanced domestic pharmaceutical production capacity.

Active

DEA Plans Schedule I Ban on Kratom Compound 7-Hydroxymitragynine

The Drug Enforcement Administration announced plans to temporarily classify 7-hydroxymitragynine (7-OH) and three related kratom-derived compounds as Schedule I controlled substances, placing them in the same category as heroin and LSD. The action would eliminate legal access to products containing these substances and criminalize possession. The policy affects thousands of Americans who use kratom products for pain management and wellness purposes.

Active

RFK Jr. remakes federal vaccine advisory panel amid Senate probe

Health Secretary Robert F. Kennedy Jr. restructured the Advisory Committee on Immunization Practices (ACIP), a key federal vaccine policy body. Senate Democrats launched an investigation into the legal and public health consequences of the panel changes. The action affects vaccine approval processes and guidance affecting millions of Americans.

Active

Most-Favored-Nation Prescription Drug Pricing Executive Order

President Trump signed Executive Order 14297 to implement Most-Favored-Nation (MFN) pricing for prescription drugs, requiring Medicare to pay no more than the lowest price paid in other developed nations. The order aims to reduce drug costs for American patients and Medicare spending by allowing the government to negotiate lower pharmaceutical prices based on international benchmarks.

Active

Regulatory Relief for Domestic Critical Medicine Production

Executive Order 14293 signed on May 5, 2025, removes regulatory barriers to increase domestic production of critical medicines in the United States. The order streamlines FDA approval processes and reduces compliance requirements for pharmaceutical manufacturers. This aims to reduce American dependence on foreign drug sources and lower medication costs for consumers.

Active

FDA purges top regulators including drug and vaccine chiefs

The Trump administration ousted FDA acting drug chief Dr. Tracy Beth Høeg, acting vaccines chief Katherine Szarama, and chief of staff Jim Traficant in a major leadership shake-up. The agency now lacks a permanent commissioner and stable leadership during critical drug approval and vaccine oversight functions. The departure of experienced regulators weakens FDA capacity to evaluate drug safety and vaccine efficacy during a period of potential regulatory rollback.

Active

Medicaid Work Requirements Implementation Nationwide

The Trump administration's budget law mandates work requirements for Medicaid beneficiaries, with Nebraska implementing the policy on May 1 and most states required to follow by January. The requirement forces many low-income Americans to prove employment to maintain health coverage, directly affecting millions of vulnerable populations who may struggle to meet work documentation standards.